Volume 21, Issue 3, 2023
Meet the Section Editor
Pp: 437-437
Author(s): Margarete Dulce Bagatini
DOI: 10.2174/1570159X2103230207100318
Published on: 07 February, 2023
Emerging Neurobiological Concepts and Therapies for Neurological Rare Diseases
Pp: 438-439
Author(s): Panagiotis Bargiotas
DOI: 10.2174/1570159X2103230207104332
Published on: 07 February, 2023
Fabry Disease: Current and Novel Therapeutic Strategies. A Narrative Review
Pp: 440-456
Author(s): Lina Palaiodimou, Panagiotis Kokotis, Christina Zompola, Georgia Papagiannopoulou, Eleni Bakola, Marianna Papadopoulou, Vasiliki Zouvelou, Dimitrios Petras, Charalampos Vlachopoulos and Georgios Tsivgoulis*
DOI: 10.2174/1570159X20666220601124117
Published on: 20 August, 2022
Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas
Pp: 457-470
Author(s): Filippos Anagnostakis and Christina Piperi*
DOI: 10.2174/1570159X20666220120120203
Published on: 01 April, 2022
Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy
Pp: 471-481
Author(s): Efthimios Dardiotis and Theodoros Kyriakides*
DOI: 10.2174/1570159X21666221108094736
Published on: 17 January, 2023
Overexpression of mTOR in Leukocytes from ALS8 Patients
Pp: 482-490
Author(s): Nathália Augusta Gomes, Francisco das Chagas Lima e Silva, Caroline Maria de Oliveira Volpe, Pedro Henrique Villar-Delfino, Camila Ferreira de Sousa, Fabiana Rocha-Silva and José Augusto Nogueira-Machado*
DOI: 10.2174/1570159X21666230201151016
Published on: 07 February, 2023
Nanotechnology-based Drug Delivery as Therapeutic Modalities for Neurological Diseases
Pp: 491-492
Author(s): Javed Ali and Sanjula Baboota
DOI: 10.2174/1570159X2103230207111522
Published on: 07 February, 2023
Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy
Pp: 493-516
Author(s): Dharmendra K. Khatri*, Kumari Preeti, Shivraj Tonape, Sheoshree Bhattacharjee, Monica Patel, Saurabh Shah, Pankaj K. Singh, Saurabh Srivastava, Dalapathi Gugulothu, Lalitkumar Vora and Shashi B. Singh*
DOI: 10.2174/1570159X20666220507022701
Published on: 19 December, 2022
Nanocarrier-Based Drug Delivery to Brain: Interventions of Surface Modification
Pp: 517-535
Author(s): Surbhi Sharma and Shweta Dang*
DOI: 10.2174/1570159X20666220706121412
Published on: 25 October, 2022
Pharmacogenomics—a New Frontier for Individualized Treatment of Parkinson’s Disease
Pp: 536-546
Author(s): Jia-Si Liu, Ying Chen, Dan-Dan Shi, Bao-Rong Zhang* and Jia-Li Pu*
DOI: 10.2174/1570159X21666221229154830
Published on: 25 January, 2023
Modelling the Interplay Between Neuron-Glia Cell Dysfunction and Glial Therapy in Autism Spectrum Disorder
Pp: 547-559
Author(s): Aziz Unnisa, Nigel H. Greig and Mohammad Amjad Kamal*
DOI: 10.2174/1570159X21666221221142743
Published on: 20 January, 2023
Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence
Pp: 560-577
Author(s): Poornima D.E. Weerasinghe-Mudiyanselage, Sohi Kang, Joong-Sun Kim and Changjong Moon*
DOI: 10.2174/1570159X20666221005090126
Published on: 02 November, 2022
mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases
Pp: 578-598
Author(s): Dehao Shang, Minghao Huang, Biyao Wang, Xu Yan, Zhou Wu and Xinwen Zhang*
DOI: 10.2174/1570159X20666220810114644
Published on: 02 November, 2022
Advanced Microfluidic Vascularized Tissues as Platform for the Study of Human Diseases and Drug Development
Pp: 599-620
Author(s): Behnam Noorani, Luca Cucullo*, Yeseul Ahn, Hossam Kadry, Aditya Bhalerao, Snehal Raut, Ehsan Nozohouri and Ekram Ahmed Chowdhury
DOI: 10.2174/1570159X20666220706112711
Published on: 21 December, 2022
Neutrophil Heterogeneity and its Roles in the Inflammatory Network after Ischemic Stroke
Pp: 621-650
Author(s): Meizhen Xie, Yulei Hao, Liangshu Feng, Tian Wang, Mengyue Yao, Hui Li, Di Ma* and Jiachun Feng*
DOI: 10.2174/1570159X20666220706115957
Published on: 08 November, 2022
Dietary Flavonoids and Adult Neurogenesis: Potential Implications for Brain Aging
Pp: 651-668
Author(s): Sergio Davinelli*, Alessandro Medoro, Sawan Ali, Daniela Passarella, Mariano Intrieri and Giovanni Scapagnini
DOI: 10.2174/1570159X21666221031103909
Published on: 03 November, 2022
Secondary White Matter Injury Mediated by Neuroinflammation after Intracerebral Hemorrhage and Promising Therapeutic Strategies of Targeting the NLRP3 Inflammasome
Pp: 669-686
Author(s): Linglong Xiao, Mengqi Wang, Yifeng Shi, Yangyang Xu, Yuan Gao, Wei Zhang, Yang Wu, Hao Deng, Wei Pan, Wei Wang* and Haitao Sun*
DOI: 10.2174/1570159X20666220830115018
Published on: 24 October, 2022
Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs
Pp: 687-707
Author(s): Enrico Marchetta, Giulia F. Mancini, Maria Morena* and Patrizia Campolongo*
DOI: 10.2174/1570159X21666221207162750
Published on: 15 December, 2022
Inflammation as Treatment Target for Status Epilepticus
Pp: 708-714
Author(s): Konrad Rejdak*, Agata Pikulicka, Małgorzata Piekarska, Katarzyna Pacek and Kamila Płachta
DOI: 10.2174/1570159X21666221117152249
Published on: 26 December, 2022
Impact of the Cannabinoid System in Alzheimer's Disease
Pp: 715-726
Author(s): Shuangtao Li, Yuanbing Huang, Lijun Yu, Xiaoyu Ji and Jie Wu*
DOI: 10.2174/1570159X20666220201091006
Published on: 19 April, 2022
